A Comparative Study of β-Amyloid Peptides Aβ1-42 and Aβ25-35 Toxicity in Organotypic Hippocampal Slice Cultures

被引:106
作者
Frozza, Rudimar Luiz [1 ]
Horn, Ana Paula [1 ]
Hoppe, Juliana Bender [1 ]
Simao, Fabricio [1 ]
Gerhardt, Danieli [1 ]
Comiran, Ricardo Argenta [1 ]
Salbego, Christianne Gazzana [1 ]
机构
[1] Univ Fed Rio Grande do Sul, Programa Posgrad Ciencias Biol Bioquim, Dept Bioquim, Inst Ciencias Basicas Saude, BR-90035003 Porto Alegre, RS, Brazil
关键词
Alzheimer's disease; Amyloid beta-peptide; Organotypic culture; Caspase-3; INDUCED NEURONAL DEATH; ALZHEIMERS-DISEASE; RAT HIPPOCAMPAL; INDUCED NEUROTOXICITY; CELL-DEATH; GLUCOSE DEPRIVATION; PROTEIN; KINASE; MECHANISMS; APOPTOSIS;
D O I
10.1007/s11064-008-9776-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulation of the neurotoxic amyloid beta-peptide (A beta) in the brain is a hallmark of Alzheimer's disease (AD). Several synthetic A beta peptides have been used to study the mechanisms of toxicity. Here, we sought to establish comparability between two commonly used A beta peptides A beta 1-42 and A beta 25-35 on an in vitro model of A beta toxicity. For this purpose we used organotypic slice cultures of rat hippocampus and observed that both A beta peptides caused similar toxic effects regarding to propidium iodide uptake and caspase-3 activation. In addition, we also did not observe any effect of both peptides on Akt and PTEN phosphorylation; otherwise the phosphorylation of GSK-3 beta was increased. Although further studies are necessary for understanding mechanisms underlying A beta peptide toxicity, our results provide strong evidence that A beta 1-42 and the A beta 25-35 peptides induce neural injury in a similar pattern and that A beta 25-35 is a convenient tool for the investigation of neurotoxic mechanisms involved in AD.
引用
收藏
页码:295 / 303
页数:9
相关论文
共 67 条
[51]   Changes in molecular isoform distribution of acetylcholinesterase in rat cortex and cerebrospinal fluid after intracerebroventricular administration of amyloid β-peptide [J].
Sáez-Valero, J ;
de Ceballos, ML ;
Small, DH ;
de Felipe, C .
NEUROSCIENCE LETTERS, 2002, 325 (03) :199-202
[52]   Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior [J].
Selkoe, Dennis J. .
BEHAVIOURAL BRAIN RESEARCH, 2008, 192 (01) :106-113
[53]   Alzheimer's disease: Molecular understanding predicts amyloid-based therapeutics [J].
Selkoe, DJ ;
Schenk, D .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2003, 43 :545-584
[54]   Amyloid beta-protein and the genetics of Alzheimer's disease [J].
Selkoe, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) :18295-18298
[55]  
Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17
[56]   Translating cell biology into therapeutic advances in Alzheimer's disease [J].
Selkoe, DJ .
NATURE, 1999, 399 (6738) :A23-A31
[57]   PRODUCTION OF THE ALZHEIMER AMYLOID-BETA PROTEIN BY NORMAL PROTEOLYTIC PROCESSING [J].
SHOJI, M ;
GOLDE, TE ;
GHISO, J ;
CHEUNG, TT ;
ESTUS, S ;
SHAFFER, LM ;
CAI, XD ;
MCKAY, DM ;
TINTNER, R ;
FRANGIONE, B ;
YOUNKIN, SG .
SCIENCE, 1992, 258 (5079) :126-129
[58]  
Smith Wanli W., 2006, CNS & Neurological Disorders-Drug Targets, V5, P355, DOI 10.2174/187152706784111515
[59]  
Song Xiuzhen, 2005, Kobe Journal of Medical Sciences, V51, P73
[60]   Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease -: Evidence for apoptotic cell death [J].
Stadelmann, C ;
Deckwerth, TL ;
Srinivasan, A ;
Bancher, C ;
Brück, W ;
Jellinger, K ;
Lassmann, H .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (05) :1459-1466